| Literature DB >> 35491409 |
Zengbo Zhao1, Huimin Wang1, Xiaona Li1, Jingya Hou1, Yuntian Yang2, Hexiang Li3.
Abstract
BACKGROUND: Periodontitis is an infectious disease, and a risk factor for peri-implantitis that could result in the implant loss. DNA methylation has an essential role in the etiology and pathogenesis of inflammatory disease. However, there is lack of study on methylation status of genes in periodontitis. This study sought to explore the gene methylation profiling microarray in periodontitis.Entities:
Keywords: Bioinformatitics; DNA methylation; Gene expression; Periodontitis
Mesh:
Year: 2022 PMID: 35491409 PMCID: PMC9058047 DOI: 10.1186/s40729-022-00420-8
Source DB: PubMed Journal: Int J Implant Dent ISSN: 2198-4034
Fig. 1Volcano plot of methylation difference in periodontitis. A total of 621 hypo-methylated and 47 hyper-methylated genes in periodontitis with p < 0.05 and [logFC] > 1. Hyper-methylated genes were represented by red point in the right side, while hypo-methylated genes were represented by blue point in the left side
Identified DMGs from data sets in periodontitis tissues
| DMGs | Gene list |
|---|---|
| Hyper-methylated | AATK, ABLIM2, ADARB2, AHR, ARHGAP10, ARHGAP39, ARPC1B,CCDC125, CCZ1B, CDC42BPA, CKLF-CMTM1, CMTM7, CSGALNACT2, DCTN5, DEGS2, DGKQ, DOCK1, ELFN1-AS1, ELFN2, FARS2, GPR155, GSTT1, HCG14, KCNJ6, KIAA1462, KNDC1, LEMD3, LRCH4, MCM5, MYO18A, NXT1, OCA2, OR8B8, OS9, PAPD7, PCM1, PLD6, PRKCZ, RET, RNF39, SOX2-OT, SPTLC2, ST5, TLE2, TMEM9B, TRPS1, TTC19 |
| Hypo-methylated | RBM20, RBM24, RBP7, RCAN1, RELN, RFX6, RHCG, RHOU, RIMS4, RNF150, RNF217, ROBO2, ROR1, RORA, SALL1, SATB2, SCARF2, SCGB3A1, SCN4B, SDK2, SEC23IP, SEMA3C, SEMA5A, SEMA6D, SH2D4A, SH3BP4, SH3GL3, SHC2, SHISA8, SIM1, SIM2, SIX3-AS1, SLAIN1, SLC15A2, SLC1A6, SLC22A17, SLC24A4, SLC25A25, SLC30A2, SLC32A1, SLC35D2, SLC38A3, SLC40A1, SLC6A2, SLC6A3, SLC9A2, SLIT1, SLIT3, SLITRK5, SLMAP, SMTNL2, SNCA, SND1, SNTG2, SNX32, SOWAHC, SOX14, SOX17, SPEG, SPOCK1, SPRY2, SPTB, SRF, SRP68, SRRM4, SSH1, ST6GAL2, ST8SIA2, STBD1, STC2, STK17B, STK24, STK32B, STK32C, SULF2, SYNDIG1L, SYNGR1, SYNM, SYPL2, SYT6, SYT9, TACC2, TACR1, TAF3, TBCD, TBR1, TBX18, TBX2, TBX2-AS1, TFAP2A-AS1, TFAP2C, TH2LCRR, THADA, THBS4, TJP1, TLL1, TLX2, TMEM132E, TMEM150B, TMEM178A, TNFRSF1B, TNIP3, TPBGL, TRAF3, TRAM2-AS1, TRIL, TRIO, TRPC6, TSPAN33, TTC34, TUB, UBE4B, UBL3, UCP1, UGGT2, UNC5A, USH1C, USP16, USP2, USP44, USP6NL, VAC14, VENTX, VIPR2, VPS53, VWC2, WBP1L, WBSCR17, WNT3A, WNT7B, WNT9B, WT1-AS, YIPF4, ZBTB8B, ZC3H3, ZFP28, ZFPM2, ZFR2, ZIC2, ZIK1, ZNF285, ZNF354C, ZNF503-AS2, ZNF542P, ZNF577, ZNF655, ZNF662, ZNF667, ZNF677, ZNF697, ZNF718, ZNF781 |
Fig. 2Top 10 Gene Ontology analysis and significantly enriched GO terms of the candidate DMGs. Up, GO analysis classified the common hypo-methylated DMGs; down, GO analysis classified the common hyper-methylated DMGs,
Top 10 significantly enrichment analysis of hyper-methylated DMGs in periodontitis tissues
| Term | Description | Count | Percentage | |
|---|---|---|---|---|
| GO:0044446 | Intracellular organelle part | 27 | 55.1020408 | 0.02155529 |
| GO:0044422 | Organelle part | 27 | 55.1020408 | 0.02927057 |
| GO:0005856 | Cytoskeleton | 10 | 20.4081633 | 0.04142009 |
| GO:0007010 | Cytoskeleton organization | 8 | 16.3265306 | 0.01722379 |
| GO:0051336 | Regulation of hydrolase activity | 8 | 16.3265306 | 0.03663579 |
| GO:0051345 | Positive regulation of hydrolase activity | 7 | 14.2857143 | 0.02043463 |
| GO:0031967 | Organelle envelope | 7 | 14.2857143 | 0.04659827 |
| GO:0031975 | Envelope | 7 | 14.2857143 | 0.04742665 |
| GO:0043547 | Positive regulation of GTPase activity | 6 | 12.244898 | 0.01054484 |
| GO:0043547 | Positive regulation of GTPase activity | 6 | 12.244898 | 0.01668003 |
Top 10 significantly enrichment analysis of hypo-methylated DMGs in periodontitis tissues
| Term | Description | Count | Percentage | |
|---|---|---|---|---|
| GO:0005634 | Nucleus | 188 | 29.8412698 | 0.02328831 |
| GO:0005886 | Plasma membrane | 167 | 26.5079365 | 3.51E-05 |
| GO:0005576 | Extracellular region | 70 | 11.1111111 | 0.00245553 |
| GO:0005887 | Integral component of plasma membrane | 66 | 10.4761905 | 5.91E-04 |
| GO:0045944 | Positive regulation of transcription from RNA Polymerase II promoter | 59 | 9.36507937 | 2.03E-06 |
| GO:0005615 | Extracellular space | 56 | 8.88888889 | 0.01627481 |
| GO:0007165 | Signal transduction | 55 | 8.73015873 | 0.00212399 |
| GO:0005509 | Calcium ion binding | 45 | 7.14285714 | 1.42E-05 |
| GO:0000122 | Negative regulation of transcription from RNA polymerase II promoter | 43 | 6.82539683 | 7.65E-05 |
| GO:0043565 | Sequence-specific DNA binding | 37 | 5.87301587 | 6.08E-06 |
Fig. 3Significantly enriched pathway terms of the candidate genes in periodontitis. Functional and signaling pathway enrichment analysis were conducted using the KEGG pathway, Reactome, and BioCyc online websites
Signaling pathway enrichment analysis of DMGs in periodontitis tissues
| Pathway identifier | Term | Regulation | Count | |
|---|---|---|---|---|
| hsa05100 | Bacterial invasion of epithelial cells | Hyper-methylated | 3 | 0.017267317 |
| hsa04071 | Sphingolipid signaling pathway | Hyper-methylated | 3 | 0.038486205 |
| R-HSA-418885 | DCC mediated attractive signaling | Hyper-methylated | 2 | 0.034928066 |
| hsa05200 | Pathways in cancer | Hypo-methylated | 31 | 3.04E-06 |
| hsa04080 | Neuroactive ligand–receptor interaction | Hypo-methylated | 20 | 8.45E-04 |
| hsa04151 | PI3K–Akt signaling pathway | Hypo-methylated | 18 | 0.0369 |
| hsa04022 | cGMP–PKG signaling pathway | Hypo-methylated | 15 | 3.04E-06 |
| hsa04015 | Rap1 signaling pathway | Hypo-methylated | 15 | 0.0053 |
| R-HSA-5673001 | RAF/MAP kinase cascad | Hypo-methylated | 14 | 6.21E-05 |
| R-HSA-416476 | G alpha (q) signalling | Hypo-methylated | 14 | 0.001925 |
| R-HSA-418594 | R-HSA-418594 | Hypo-methylated | 14 | 0.044195 |
| hsa04550 | Signaling pathways regulating pluripotency of stem cells | Hypo-methylated | 13 | 0.0012 |
| hsa04020 | Calcium signaling pathway | Hypo-methylated | 13 | 0.0091 |
| hsa04062 | Chemokine signaling pathway | Hypo-methylated | 13 | 0.0121 |
| hsa04810 | Regulation of actin cytoskeleton | Hypo-methylated | 13 | 0.0287 |
| hsa04360 | Axon guidance | Hypo-methylated | 12 | 0.0018 |
| hsa04921 | Oxytocin signaling pathway | Hypo-methylated | 12 | 0.0064 |
| hsa04724 | Glutamatergic synapse | Hypo-methylated | 11 | 0.0026 |
| hsa04728 | Dopaminergic synapse | Hypo-methylated | 11 | 0.006 |
| hsa04390 | Hippo signaling pathway | Hypo-methylated | 11 | 0.0179 |
| R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K | Hypo-methylated | 10 | 1.03E-04 |
| R-HSA-1257604 | PIP3 activates AKT signaling | Hypo-methylated | 10 | 8.96E-04 |
| hsa04713 | Circadian entrainment | Hypo-methylated | 10 | 0.0025 |
| hsa04916 | Melanogenesis | Hypo-methylated | 10 | 0.0035 |
| hsa04723 | Retrograde endocannabinoid signaling | Hypo-methylated | 10 | 0.0038 |
| hsa04540 | Gap junction | Hypo-methylated | 9 | 0.0055 |
| hsa04915 | Estrogen signaling pathway | Hypo-methylated | 9 | 0.0111 |
| R-HSA-1650814 | Collagen biosynthesis and modifying enzymes | Hypo-methylated | 8 | 0.004679 |
| hsa04971 | Gastric acid secretion | Hypo-methylated | 8 | 0.007 |
| hsa04925 | Aldosterone synthesis and secretion | Hypo-methylated | 8 | 0.0121 |
| hsa05100 | Bacterial invasion of epithelial cells | Hypo-methylated | 7 | 0.0326 |
| hsa04727 | GABAergic synapse | Hypo-methylated | 7 | 0.0466 |
| R-HSA-109704 | PI3K Cascade | Hypo-methylated | 6 | 0.004858 |
| R-HSA-373080 | Class B/2 (Secretin family receptors) | Hypo-methylated | 6 | 0.016312 |
| hsa04710 | Circadian rhythm | Hypo-methylated | 6 | 0.0023 |
| hsa05217 | Basal cell carcinoma | Hypo-methylated | 6 | 0.0247 |
| hsa04923 | Regulation of lipolysis in adipocytes | Hypo-methylated | 6 | 0.0284 |
| hsa04730 | Long-term depression | Hypo-methylated | 6 | 0.0368 |
| hsa04924 | Renin secretion | Hypo-methylated | 6 | 0.0466 |
| R-HSA-170670 | Adenylate cyclase inhibitory pathway | Hypo-methylated | 4 | 0.008461 |
| R-HSA-112043 | PLC beta mediated events | Hypo-methylated | 4 | 0.012432 |
| R-HSA-1566948 | Elastic fibre formation | Hypo-methylated | 4 | 0.017303 |
| R-HSA-373752 | Netrin-1 signaling | Hypo-methylated | 4 | 0.020083 |
| R-HSA-381426 | Regulation of Insulin-like Growth Factor | Hypo-methylated | 4 | 0.026335 |
| hsa04950 | Maturity onset diabetes of the young | Hypo-methylated | 4 | 0.0446 |
| hsa04340 | Hedgehog signaling pathway | Hypo-methylated | 4 | 0.049 |
| h_rac1Pathway | Rac 1 cell motility signaling pathway | Hypo-methylated | 4 | 0.038391 |
| R-HSA-5362798 | Release of Hh-Np from the secreting cell | Hypo-methylated | 3 | 0.023963 |
| R-HSA-3371599 | Defective HLCS causes multiple carboxylase deficiency | Hypo-methylated | 3 | 0.023963 |
| R-HSA-170660 | Adenylate cyclase activating pathway | Hypo-methylated | 3 | 0.036964 |
| R-HSA-196780 | Biotin transport and metabolism | Hypo-methylated | 3 | 0.044264 |
| R-HSA-2243919 | Crosslinking of collagen fibrils | Hypo-methylated | 3 | 0.044264 |
| h_akap13Pathway | Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation | Hypo-methylated | 3 | 0.049203 |
Fig. 4Protein–protein interaction (PPI) network and modular analysis of the DMGs in periodontitis. A Using the STRING online database, a total of 630 nodes (red represents hypo-methylated genes, and blue represents hyper-methylated genes) and 1790 interactions were identified in the DMG PPI network. B Top 10 genes in network string interactions by Degree method
Top 10 genes in network string interactions ranked by degree method
| Rank | Gene name | Score |
|---|---|---|
| 1 | APP | 61 |
| 2 | PAX6 | 43 |
| 3 | LPAR1 | 33 |
| 4 | WNT3A | 31 |
| 5 | BMP2 | 30 |
| 6 | PIK3R2 | 29 |
| 7 | GATA4 | 27 |
| 7 | PLCB1 | 27 |
| 9 | GATA6 | 26 |
| 9 | CXCL12 | 26 |